The two companies will work together to develop gene therapies in oncology.
Mike Hollan
Advertisement
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Articles by Mike Hollan
The plan is focused on providing financial incentives for treatments that improve the patients’ health equity.
The CEO of Outcomes discusses how local pharmacies are playing an important role in improving health equity.
The vice president of technology strategy & strategic partnerships at Syneos Health discusses how new digital technologies are changing the ways that data is collected, shared, analyzed.
The CEO of NewYorkBIO discusses why investors continue to flock to New York in the life sciences industry.
Blankenship, vice president of policy initiatives and advocacy at The Academy of Nutrition and Dietetics, discusses how AOMs can play a role in creating strategies to manage the obesity epidemic.
The lawsuit, filed the department of labor, alleges that Blue Cross improperly collected provider taxes from self-funded employer health plans.
PanOmiQ is referred to as the fasted technology of its kind by the company.
Melton, VP of scientific operations and development at Slope, discusses how new technologies can be used to ensure data is accurate.
The center will offer local residents with opportunities and training to enter the pharmacy work force.
Sanders wrote a letter to Novo Nordisk announcing the investigation.
LabConnect will utilize the consulting firm’s assets to improve its clinical trial services.
The new tests are reportedly more accurate at detecting early-stage pancreatic cancer.
Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion
The MagicTouch will be the focus of the Magical-ISR study.
Alder, CEO of Gain Therapeutics, discusses how the Magellan platform was used in the creation of GT-02287.
While human infections of the virus are rare, a strain recently appeared in dairy cows before infecting a human in Texas.
Rahman discusses the new opportunities that digital twins present to researchers.
The council was established as part of NORD’s Project RDAC.
The Health Cube will increase remote and virtual care options for populations living in remote areas.
BrandShield states that it has identified sites selling counterfeit versions of Wegovy and Ozempic, among other drugs.
Butta discusses how new technologies are being implemented in at-home devices.
Tava’s network of therapists will be added to Health Advocate’s existing network.
Damien Bailly, president of established markets at Astellas, discusses why partnerships and collaborations are a critical organizational—and wider ecosystem—imperative in ensuring that patients have access to the medicines they need.
Users will be able to access DeepScribe’s documentation platform through AWS.
The program is designed to tackle issues related to the high cost of prescription medication.
This facility is the first of four facilities to be built in the area.
The meeting is scheduled for May in Switzerland.
The vaccine is already approved for older adults.
The move is part of Synaptogenix’s partnership with Cannasoul.
Advertisement